Exploring IRC Section 382: An Essential Consideration for Life Sciences Entities
Withum
JANUARY 22, 2024
This is problematic, as the intricacies of Section 382 potentially hinder the strategic use of historic NOLs. Section 382’s inception aimed to curb the misuse of NOLs, particularly through ownership changes. Ownership changes often arise from mergers and acquisitions (M&A) or multiple rounds of equity financing.
Let's personalize your content